IPC Healthcare Expands Post-Acute Market Presence in Wichita

NORTH HOLLYWOOD, Calif., Nov. 13, 2015 (GLOBE NEWSWIRE) -- IPC Healthcare, Inc. (Nasdaq: IPCM), a leading national acute hospitalist and post-acute provider organization, announced today that it has acquired Amity Health, LLC, in Wichita, Kansas. The acquisition complements IPC's existing market presence for acute and post-acute services in the Wichita area.

R. Jeffrey Taylor, president and COO of IPC Healthcare, stated, "Amity's focus on post-acute services will help complement and broaden our capabilities for population health management in the Wichita area, where IPC has had an established presence since 2013. With the Amity acquisition, we will be adding several additional post-acute facilities and clinicians to IPC's footprint in the market. We are pleased to welcome the Amity team to our IPC family."

This acquisition is expected to add more than 13,000 encounters on a combined annualized basis.

About IPC Healthcare, Inc.

IPC Healthcare, Inc. (Nasdaq: IPCM) is a leading national acute hospitalist and post-acute provider group practice company. IPC Healthcare's affiliated physicians and other clinical providers practice in approximately 400 hospitals and 2,000 post-acute care facilities. The Company offers its more than 2,000 employed clinicians comprehensive training, information technology, and management support systems to improve the quality and reduce the cost of patient care in the facilities it serves. For more information, visit the IPC Healthcare website at www.ipchealthcare.com.

CONTACT: Media Contact:
         Scott Public Relations
         Elaine Murphy
         818.610.0270
         [email protected]

         Investor Contact:
         PondelWilkinson
         Evan Pondel
         310.279.5980
         [email protected]

You May Also Be Interested In

• Villa Marconi Engaged in Union Busting as Agency Staff Are Hired to Fill Union Positions
• BioMedNewsBreaks — VERAXA Biotech AG (NASDAQ: VRXA) Builds Strategic Position in Antibody Therapeutics Market
• Star Equity Holdings to Release Second Quarter 2026 Financial Results on August 14